1. Álvarez-Sabín, J, Maisterra, O, Santamarina, E, et al Factors influencing haemorrhagic transformation in ischaemic stroke. Lancet Neurol 2013; 12: 689–705.
Google Scholar | Crossref | Medline | ISI2. Fiorelli, M, Bastianello, S, von Kummer, R, et al Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort. Stroke 1999; 30: 2280–2284.
Google Scholar | Crossref | Medline | ISI3. Berger, C, Fiorelli, M, Steiner, T, et al Hemorrhagic transformation of ischemic brain tissue asymptomatic or symptomatic? Stroke 2001; 32: 1330–1335.
Google Scholar | Crossref | Medline | ISI4. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group . Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995; 14: 1581–1587.
Google Scholar5. Goldstein, JN, Marrero, M, Masrur, S, et al Management of thrombolysis-associated symptomatic intracerebral hemorrhage. Arch Neurol 2010; 67: 965–969.
Google Scholar | Crossref | Medline6. Alderazi, YJ, Barot, NV, Peng, H, et al Clotting factors to treat thrombolysis-related symptomatic intracranial hemorrhage in acute ischemic stroke. J Stroke Cerebrovasc Dis 2014; 23: e207–e214.
Google Scholar | Crossref | Medline7. Yaghi, S, Boehme, AK, Dibu, J, et al Treatment and outcome of thrombolysis-related hemorrhage. JAMA Neurol 2015; 72: 1451–1457.
Google Scholar | Crossref | Medline | ISI8. Yaghi, S, Willey, JZ, Cucchiara, B, et al Treatment and outcome of hemorrhagic transformation after intravenous alteplase in acute ischemic stroke a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2017; 48: e343–e361.
Google Scholar | Crossref9. Kumar, V, Gu, Y, Basu, S, et al Radiomics: the process and the challenges. Magn Reson Imaging 2012; 30: 1234–1248.
Google Scholar | Crossref | Medline | ISI10. Gillies, RJ, Kinahan, PE, Hricak, H. Radiomics: images are more than pictures, they are data. Radiology 2016; 278: 563–577.
Google Scholar | Crossref | Medline11. Davnall, F, Yip, CSP, Ljungqvist, G, et al Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice. Insights Imaging 2012; 3: 573–589.
Google Scholar | Crossref | Medline12. Hu, TD, Wang, SP, Huang, L, et al A clinical-radiomics nomogram for the preoperative prediction of lung metastasis in colorectal cancer patients with indeterminate pulmonary nodules. Eur Radiol 2019; 29: 439–449.
Google Scholar | Crossref | Medline13. Chen, Q, Zhu, D, Liu, J, et al Clinical-radiomics nomogram for risk estimation of early hematoma expansion after acute intracerebral hemorrhage. Acad Radiol 2021; 28: 307–317.
Google Scholar | Crossref | Medline14. Xu, W, Ding, Z, Shan, Y, et al A nomogram model of radiomics and satellite sign number as imaging predictor for intracranial hematoma expansion. Front Neurosci 2020; 14: 491.
Google Scholar | Crossref | Medline15. Liu, J, Zheng, L, Cheng, Y, et al Trends in outcomes of patients with ischemic stroke treated between 2002 and 2016: insights from a Chinese cohort. Circ Cardiovasc Qual Outcomes 2019; 12: e005610.
Google Scholar | Crossref16. de Los Ríos la Rosa, F, Khoury, J, Kissela, BM, et al Eligibility for intravenous recombinant tissue-type plasminogen activator within a population: the effect of the European Cooperative Acute Stroke Study (ECASS) III trial. Stroke 2012; 43: 1591–1595.
Google Scholar | Crossref | Medline | ISI17. Delgado, P, Sahuquillo, J, Poca, MA, et al Neuroprotection in malignant MCA infarction. Cerebrovasc Dis 2006; 21: 99–105.
Google Scholar | Crossref | Medline18. Li, Q, Zhang, G, Huang, YJ, et al Blend sign on computed tomography: novel and reliable predictor for early hematoma growth in patients with intracerebral hemorrhage. Stroke 2015; 46: 2119–2123.
Google Scholar | Crossref | Medline19. Li, Q, Liu, QJ, Yang, WS, et al Island sign: an imaging predictor for early hematoma expansion and poor outcome in patients with intracerebral hemorrhage. Stroke 2017; 48: 3019–3025.
Google Scholar | Crossref | Medline20. Al-Nakshabandi, NA . The swirl sign. Radiology 2001; 218: 433.
Google Scholar | Crossref | Medline21. Turner, RJ, Sharp, FR. Implications of MMP9 for blood brain barrier disruption and hemorrhagic transformation following ischemic stroke. Front Cell Neurosci 2016; 10: 56.
Google Scholar | Crossref | Medline22. Świtońska, M, Piekuś-Słomka, N, Słomka, A, et al Neutrophil-to-lymphocyte ratio and symptomatic hemorrhagic transformation in ischemic stroke patients undergoing revascularization. Brain Sci 2020; 10: 771.
Google Scholar | Crossref23. Brott, T, Broderick, J, Kothari, R, et al Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 1997; 28: 1–5.
Google Scholar | Crossref | Medline | ISI24. Davis, SM, Broderick, J, Hennerici, M, et al Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology 2006; 66: 1175–1181.
Google Scholar | Crossref | Medline | ISI25. Yaghi, S, Dibu, J, Achi, E, et al Hematoma expansion in spontaneous intracerebral hemorrhage: predictors and outcome. Int J Neurosci 2014; 124: 890–893.
Google Scholar | Crossref | Medline | ISI